Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

New research reveals promising drug targets to block coronaviruses at multiple stages of infection—even across different ...

From L-R, Garcia, Wahl and Battaglia Approximately 15 million to 20 million Americans who have acquired COVID-19 experience ...

Despite vaccines and treatments, SARS-CoV-2-the virus that causes COVID-19-continues to pose a global health threat, driven ...

Scientists have discovered that the body’s immune system strongly reacts to an internal protein from SARS-CoV-2, the virus ...

In maintenance hemodialysis (MHD) patients infected with SARS-CoV-2, various thromboembolic complications have been reported, ...

It is well-established that COVID-19 is a systemic disease. Besides the respiratory system, the virus can infect different ...

Despite vaccines and treatments, SARS-CoV-2-the virus that causes COVID-19-continues to pose a global health threat, driven ...

An organoid platform has been designed to enable accurate assessment of antibodies and vaccines against SARS-CoV-2.

Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the continuing need for SARS-CoV-2 treatments for individuals with weakened immune systems, who are at the highest ...